Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
- Senan, S.
- Özgüroğlu, M.
- Daniel, D.
- Villegas, A.
- Vicente, D.
- Murakami, S.
- Hui, R.
- Faivre-Finn, C.
- Paz-Ares, L.
- Wu, Y.L.
- Mann, H.
- Dennis, P.A.
- Antonia, S.J.
Journal:
ESMO Open
ISSN: 2059-7029
Year of publication: 2022
Volume: 7
Issue: 2
Type: Article